Upcoming Legal Deadlines for Hims & Hers Health Investors
Investors are being reminded by Kahn Swick & Foti, LLC, of the pressing need to act regarding class action lawsuits involving Hims & Hers Health, Inc. If you have suffered losses exceeding $100,000, you should be aware that the deadline to file lead plaintiff applications is approaching. The cut-off date for these applications is August 25, 2025, a significant date for those participating in the legal proceedings surrounding the company's securities.
Background on the Lawsuits
The lawsuits address serious allegations against Hims & Hers Health and its executives, who are accused of failing to disclose essential information to investors during a specified class period. These leads were particularly emphasized when, on June 23, 2025, Novo Nordisk announced the termination of its partnership with Hims. This announcement claimed that Hims had not adhered to regulations governing mass sales of compounded drugs and had engaged in misleading marketing practices that jeopardized patient safety.
Impact of Recent Announcements
This news translated directly into a considerable dip in Hims' stock, falling by $22.24, approximately 34.6%, to close at $41.98 per share on June 23. Such substantial declines in share value highlight the risks faced by investors and the serious nature of the allegations tied to these lawsuits. The initial lawsuit, Sookdeo v. Hims & Hers Health, Inc., which pioneered these claims, has opened the door for subsequent cases, including Yaghsizian v. Hims & Hers Health, Inc., amplifying the class period for these legal actions.
How Investors Can Respond
For anyone who invested in Hims and is concerned about their legal rights, consultancy with Kahn Swick & Foti is encouraged. Interested parties can reach out to Managing Partner Lewis Kahn for a no-obligation discussion about their case and rights to potential recovery for economic losses. Investors are encouraged to act promptly, with the upcoming deadline looming in late August.
Contact Information
To connect, please feel free to call Lewis Kahn at 1-877-515-1850 or reach out via email at lewis.kahn@ksfcounsel.com. Furthermore, additional information on ongoing cases can be found through KSF's official channels.
About Kahn Swick & Foti, LLC
Kahn Swick & Foti, LLC (KSF) stands out as a renowned securities litigation law firm headquartered in New York. Boasting numerous accolades, including ranking among the top 10 firms nationally by SCAS based on settlement values, KSF diligently works to recover losses incurred by investors due to corporate misconduct. Their client base includes both retail and institutional investors.
KSF’s Reach and Expertise
With offices not just in New York but also in Delaware, California, Chicago, New Jersey, Louisiana, and even Luxembourg, KSF efficiently serves a wide array of clients. Their reputation is built on successful recovery from various corporate fraud cases, ensuring that investors have recourse in times of significant financial loss.
Frequently Asked Questions
What is the significance of the August 25 deadline?
This date marks the last opportunity for affected investors to apply as lead plaintiffs in the class action lawsuits against Hims & Hers Health.
How can I file a claim or learn more?
You can contact Kahn Swick & Foti directly for guidance on filing a claim and understanding your rights as an investor.
What are the main allegations against Hims & Hers Health?
The main accusations include failing to reveal crucial operational issues that negatively impacted stock prices and investor confidence.
Who can join the class action?
Investors who purchased Hims & Hers Health securities and incurred losses over a specified amount during the class period are eligible to join.
What happens if I miss the deadline?
Missing the deadline may disallow your chance to recover losses through the class action lawsuit, so timely action is crucial.
